Jl. Ellis et al., PHARMACOLOGICAL EXAMINATION OF RECEPTORS MEDIATING CONTRACTILE RESPONSES TO TACHYKININS IN AIRWAYS ISOLATED FROM HUMAN, GUINEA-PIG AND HAMSTER, The Journal of pharmacology and experimental therapeutics, 267(1), 1993, pp. 95-101
The abilities of agonists selective for neurokinin (NK)-l (Ac-[Arg6,Sa
r9,Met(O2)11]-SP6-11,ASMSP), NK-2([beta-Ala8]-NKA4-10) and NK-3 ([ASp5
,6,MePhe8]-SP5-11, senktide analog) receptors to contract human bronch
us and guinea pig and hamster trachea were studied. The antagonism of
these responses by selective antagonists was also examined. In the hum
an bronchus and hamster trachea, [beta-Ala8]-NKA4-1 0 was the most pot
ent agonist, whereas ASMSP and senktide analog failed to elicit contra
ctions greater than 50% of the maximum response even at concentrations
reaching 1 to 3 x 10(-4) M. By contrast, both ASMSP and [beta-Ala8]-N
KA4-1 0 were potent contractile agonists in guinea pig trachea. In all
tissues, the selective NK-1 receptor antagonist yphenyl)-methyl]-1-az
abicyclo-[2.2.2]octan-3-amine (CP 96,345) was without effect on contra
ctile responses to [beta-Ala8]-NKA4-1 0. Blockade by CP 96,345 of resp
onses to ASMSP was, however, observed in the guinea pig trachea, but n
ot in human bronchus or hamster trachea. Responses to ASMSP in human b
ronchus and hamster trachea were inhibited by NK-2 antagonists whereas
these compounds had little effect on responses to ASMSP in guinea pig
trachea. In all tissue types, responses to senktide analog were inhib
ited by NK-2 antagonists. The NK-2 selective antagonists Ac-Leu-Asp-Gl
y-Trp-Phe-Gly-NH2 (R 396) H-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2 (MEN
10,376) and (S)-N-methyl-N[4-(4-acetylamino-4-phenyl piperidino)-2-(3
,4-dichlorophenyl)butyl] benzamide (SR 48,968) blocked responses to [b
eta-Ala8]-NKA4-10 in human bronchus, guinea pig trachea and hamster tr
achea. The rank order of potency in human bronchus was SR 48,968 > MEN
10,376 greater-than-or-equal-to R 396. A similar order was obtained i
n the guinea pig trachea (SR 48,968 > MEN 10,376 > R 396), whereas in
the hamster trachea, the rank order of potency was SR 48,968 > R 396 >
MEN 10,376. These results suggest that tachykinin-induced contraction
s of human bronchus and hamster trachea are mediated by only NK-2-type
receptors, whereas contractions of the guinea pig trachea involve act
ivation of both NK-1- and NK-2-type receptors. Moreover it is evident
that the NK-2 receptor subtypes in the human bronchus and guinea pig t
rachea are similar to one another, but different pharmacologically fro
m the NK-2 receptor found in the hamster trachea. Subtle differences a
ppear to exist between human and guinea pig airway NK-2-type receptors
.